Recruiting
Phase 1
Phase 2

Clemastine Fumarate

Sponsor:

University of Colorado, Denver

Code:

NCT07304024

Conditions

Central Auditory Processing Disorder

Hearing Impaired (Partially)

Hearing

Hearing Abnormality

Hearing Disability

Eligibility Criteria

Sex: All

Age: 45 - 65

Healthy Volunteers: Not accepted

Interventions

Clemastine Fumarate Combined With Engineered Sound

Clemastine Fumarate Combined With Pink Noise

Placebo Drug With Engineered Sound

Placebo - Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-21. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2025-12-26.